Growth Dragons

Growth Dragons

Share this post

Growth Dragons
Growth Dragons
Growth Dragons Weekly: China Stocks Down in First Week; BYD Overtakes Tesla; Mixue Files for IPO
Weekly Report

Growth Dragons Weekly: China Stocks Down in First Week; BYD Overtakes Tesla; Mixue Files for IPO

Alvin Chow's avatar
Alvin Chow
Jan 06, 2024
∙ Paid
5

Share this post

Growth Dragons
Growth Dragons
Growth Dragons Weekly: China Stocks Down in First Week; BYD Overtakes Tesla; Mixue Files for IPO
Share

Here’s what happened in Growth Dragons this week:

  1. Bumpy Start for China Stocks and Economy in 2024

  2. ASML Halts China Orders Before Ban Officially Takes Effect

  3. Baidu Says No to Joyy

  4. BYD Knocks Tesla Off Its Throne

  5. Mixue and Goodme Apply for IPO


#1 Bumpy Start for China Stocks and Economy in 2024

China stocks did not have a hopeful start as the iShares MSCI China ETF fell by 1.31% in the first week of trading in 2024. Of course, it is still early in the year, and one might argue that the S&P 500 ETF also didn’t start well, experiencing a 0.9% decline. The key difference is that the S&P 500 was up by 26% last year, while China equities have generally been down for the last three years. This context makes the hope for a rebound in Chinese stocks even more pressing.

The Caixin/S&P Global manufacturing PMI increased to 50.8 at the end of 2023, up from 50.7 in November, marking the fastest expansion in seven months and surpassing analysts' forecasts of 50.4.

In contrast, December’s official manufacturing Purchasing Managers’ Index (PMI) fell to 49 from November’s 49.4, according to data from the National Bureau of Statistics.

The discrepancy in the PMI readings stems from the National Bureau of Statistics surveying larger companies and state-owned enterprises, while Caixin’s survey has greater representation from smaller, privately-owned companies.

Considering the entirety of 2023, the PMI rose by 0.8, which is impressive given the macroeconomic and internal economic headwinds. China's post-COVID recovery is slower than expected, as domestic demand will take time to recover, but it is underway.

We believe that China will recover; it remains a crucial centerpiece of the global supply chain, but expectations need to be realistic. It is not the year to expect a parabolic reversal to cover the losses of the last three years. A modest positive return for the MSCI China Index in 2024 would be a good sign.

#2 ASML Halts China Orders Before Ban Officially Takes Effect

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Dr Wealth
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share